Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02574728
Title Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

neuroblastoma

rhabdomyosarcoma

sarcoma

Advanced Solid Tumor

brain cancer

bone cancer

renal Wilms' tumor

Therapies

Celecoxib + Cyclophosphamide + Etoposide + Sirolimus

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.